close

The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit

CERRITOS, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology practices in the country, today announced that Dr. Daniel Virnich, TOI’s Chief Executive Officer, will participate in the “Defining the Next Chapter in Value-Based Care” panel at the Leerink Healthcare Transformation Summit in Montecito at 8:30am ET on May 16, 2024.

About The Oncology Institute, Inc.

Founded in 2007, The Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of more than 1.8 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 110+ employed clinicians and over 70 clinic locations and growing, TOI is changing oncology for the better. For more information visit www.theoncologyinstitute.com.

Investors
Solebury Strategic Communications
investors@theoncologyinstitute.com


Primary Logo

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  208.30
+3.03 (1.48%)
AAPL  274.03
+7.85 (2.95%)
AMD  210.38
+13.78 (7.01%)
BAC  49.99
-1.08 (-2.11%)
GOOG  310.66
-1.03 (-0.33%)
META  637.24
-0.01 (-0.00%)
MSFT  386.72
+2.25 (0.59%)
NVDA  192.46
+0.91 (0.47%)
ORCL  145.01
+3.70 (2.62%)
TSLA  404.01
+4.19 (1.05%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Starting at $3.75/week.

Subscribe Today